These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28159577)

  • 1. A tuberculosis biomarker database: the key to novel TB diagnostics.
    Yerlikaya S; Broger T; MacLean E; Pai M; Denkinger CM
    Int J Infect Dis; 2017 Mar; 56():253-257. PubMed ID: 28159577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
    Denkinger CM; Schumacher SG; Gilpin C; Korobitsyn A; Wells WA; Pai M; Leeflang M; Steingart KR; Bulterys M; Schünemann H; Glaziou P; Weyer K
    J Infect Dis; 2019 Oct; 220(220 Suppl 3):S91-S98. PubMed ID: 31593596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.
    Kaufmann SHE; Weiner J; Maertzdorf J
    Expert Rev Vaccines; 2017 Aug; 16(8):845-853. PubMed ID: 28608729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten challenges for TB biomarkers.
    Ottenhoff TH; Ellner JJ; Kaufmann SH
    Tuberculosis (Edinb); 2012 Mar; 92 Suppl 1():S17-20. PubMed ID: 22441153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic biomarkers for active tuberculosis: progress and challenges.
    Nogueira BMF; Krishnan S; Barreto-Duarte B; Araújo-Pereira M; Queiroz ATL; Ellner JJ; Salgame P; Scriba TJ; Sterling TR; Gupta A; Andrade BB
    EMBO Mol Med; 2022 Dec; 14(12):e14088. PubMed ID: 36314872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis.
    De Groote MA; Sterling DG; Hraha T; Russell TM; Green LS; Wall K; Kraemer S; Ostroff R; Janjic N; Ochsner UA
    J Clin Microbiol; 2017 Oct; 55(10):3057-3071. PubMed ID: 28794177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.
    Pai M; Schito M
    J Infect Dis; 2015 Apr; 211 Suppl 2(Suppl 2):S21-8. PubMed ID: 25765103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enabling biomarkers for tuberculosis control.
    Maertzdorf J; Weiner J; Kaufmann SH
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1140-8. PubMed ID: 22871324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New diagnostics for tuberculosis: fulfilling patient needs first.
    Lemaire JF; Casenghi M
    J Int AIDS Soc; 2010 Oct; 13():40. PubMed ID: 20973946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential market for novel tuberculosis diagnostics: worth the investment?
    Kik SV; Denkinger CM; Jefferson C; Ginnard J; Pai M
    J Infect Dis; 2015 Apr; 211 Suppl 2():S58-66. PubMed ID: 25765107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment.
    Jacobs R; Tshehla E; Malherbe S; Kriel M; Loxton AG; Stanley K; van der Spuy G; Walzl G; Chegou NN
    Cytokine; 2016 May; 81():50-6. PubMed ID: 26878648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis: a new vision for the 21st century.
    Small PM
    Kekkaku; 2009 Nov; 84(11):721-6. PubMed ID: 19999594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis: lights and shadows in the current diagnostic landscape.
    Norbis L; Miotto P; Alagna R; Cirillo DM
    New Microbiol; 2013 Apr; 36(2):111-20. PubMed ID: 23686117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Tuberculosis: The Impact of "Omics" on Diagnostics Development.
    Jakhar S; Bitzer AA; Stromberg LR; Mukundan H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viewpoint TB diagnostics: what does the world really need?
    Weyer K; Carai S; Nunn P
    J Infect Dis; 2011 Nov; 204 Suppl 4():S1196-202. PubMed ID: 21996702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis.
    Bates M; Zumla A
    Expert Rev Mol Diagn; 2016; 16(3):307-22. PubMed ID: 26735769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.